vs
Immunovant, Inc.(IMVT)与UNITED SECURITY BANCSHARES(UBFO)财务数据对比。点击上方公司名可切换其他公司
UNITED SECURITY BANCSHARES的季度营收约是Immunovant, Inc.的1.6倍($13.5M vs $8.4M),UNITED SECURITY BANCSHARES净利率更高(25.2% vs -899.0%,领先924.2%),Immunovant, Inc.同比增速更快(140.7% vs 13.6%),UNITED SECURITY BANCSHARES自由现金流更多($19.8M vs $-59.8M)
Immunovant是一家临床阶段生物制药企业,专注于开发用于治疗严重、罕见自身免疫性疾病及炎症性疾病的新型单克隆抗体疗法,其核心在研候选产品覆盖多种自身免疫适应症,面向全球医疗市场布局研发管线。
联合安全银行控股公司(United Security Bancshares)是一家银行控股公司,总部位于加利福尼亚州弗雷斯诺,目前在当地共运营11家线下分支网点。
IMVT vs UBFO — 直观对比
营收规模更大
UBFO
是对方的1.6倍
$8.4M
营收增速更快
IMVT
高出127.2%
13.6%
净利率更高
UBFO
高出924.2%
-899.0%
自由现金流更多
UBFO
多$79.6M
$-59.8M
损益表 — Q4 FY2024 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $8.4M | $13.5M |
| 净利润 | $-75.3M | $3.4M |
| 毛利率 | — | — |
| 营业利润率 | -896.2% | 31.5% |
| 净利率 | -899.0% | 25.2% |
| 营收同比 | 140.7% | 13.6% |
| 净利润同比 | -26.7% | 36.8% |
| 每股收益(稀释后) | $-0.50 | $0.18 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
IMVT
UBFO
| Q4 25 | — | $13.5M | ||
| Q3 25 | — | $14.0M | ||
| Q2 25 | — | $12.6M | ||
| Q1 25 | — | $13.7M | ||
| Q4 24 | — | $11.9M | ||
| Q3 24 | — | $13.8M | ||
| Q2 24 | — | $13.0M | ||
| Q1 24 | $8.4M | $12.8M |
净利润
IMVT
UBFO
| Q4 25 | — | $3.4M | ||
| Q3 25 | — | $4.0M | ||
| Q2 25 | — | $2.2M | ||
| Q1 25 | — | $2.7M | ||
| Q4 24 | — | $2.5M | ||
| Q3 24 | — | $3.8M | ||
| Q2 24 | — | $4.3M | ||
| Q1 24 | $-75.3M | $4.2M |
营业利润率
IMVT
UBFO
| Q4 25 | — | 31.5% | ||
| Q3 25 | — | 40.3% | ||
| Q2 25 | — | 24.0% | ||
| Q1 25 | — | 27.5% | ||
| Q4 24 | — | 27.5% | ||
| Q3 24 | — | 37.1% | ||
| Q2 24 | — | 46.4% | ||
| Q1 24 | -896.2% | 45.9% |
净利率
IMVT
UBFO
| Q4 25 | — | 25.2% | ||
| Q3 25 | — | 28.7% | ||
| Q2 25 | — | 17.2% | ||
| Q1 25 | — | 19.6% | ||
| Q4 24 | — | 20.9% | ||
| Q3 24 | — | 27.7% | ||
| Q2 24 | — | 33.0% | ||
| Q1 24 | -899.0% | 32.6% |
每股收益(稀释后)
IMVT
UBFO
| Q4 25 | — | $0.18 | ||
| Q3 25 | — | $0.23 | ||
| Q2 25 | — | $0.13 | ||
| Q1 25 | — | $0.16 | ||
| Q4 24 | — | $0.14 | ||
| Q3 24 | — | $0.22 | ||
| Q2 24 | — | $0.25 | ||
| Q1 24 | $-0.50 | $0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $635.4M | $264.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $617.8M | $139.7M |
| 总资产 | $666.4M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
IMVT
UBFO
| Q4 25 | — | $264.2M | ||
| Q3 25 | — | $211.1M | ||
| Q2 25 | — | $199.5M | ||
| Q1 25 | — | $198.4M | ||
| Q4 24 | — | $216.9M | ||
| Q3 24 | — | $216.8M | ||
| Q2 24 | — | $166.3M | ||
| Q1 24 | $635.4M | $168.6M |
股东权益
IMVT
UBFO
| Q4 25 | — | $139.7M | ||
| Q3 25 | — | $137.4M | ||
| Q2 25 | — | $134.3M | ||
| Q1 25 | — | $132.9M | ||
| Q4 24 | — | $130.4M | ||
| Q3 24 | — | $132.9M | ||
| Q2 24 | — | $127.3M | ||
| Q1 24 | $617.8M | $124.2M |
总资产
IMVT
UBFO
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | $666.4M | $1.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-59.7M | $22.1M |
| 自由现金流经营现金流 - 资本支出 | $-59.8M | $19.8M |
| 自由现金流率自由现金流/营收 | -714.4% | 146.0% |
| 资本支出强度资本支出/营收 | 1.8% | 16.8% |
| 现金转化率经营现金流/净利润 | — | 6.46× |
| 过去12个月自由现金流最近4个季度 | $-214.6M | $36.9M |
8季度趋势,按日历期对齐
经营现金流
IMVT
UBFO
| Q4 25 | — | $22.1M | ||
| Q3 25 | — | $7.0M | ||
| Q2 25 | — | $8.7M | ||
| Q1 25 | — | $3.0M | ||
| Q4 24 | — | $19.6M | ||
| Q3 24 | — | $5.4M | ||
| Q2 24 | — | $2.3M | ||
| Q1 24 | $-59.7M | $7.4M |
自由现金流
IMVT
UBFO
| Q4 25 | — | $19.8M | ||
| Q3 25 | — | $6.1M | ||
| Q2 25 | — | $8.1M | ||
| Q1 25 | — | $2.9M | ||
| Q4 24 | — | $18.6M | ||
| Q3 24 | — | $5.3M | ||
| Q2 24 | — | $2.0M | ||
| Q1 24 | $-59.8M | $7.0M |
自由现金流率
IMVT
UBFO
| Q4 25 | — | 146.0% | ||
| Q3 25 | — | 43.7% | ||
| Q2 25 | — | 64.3% | ||
| Q1 25 | — | 21.2% | ||
| Q4 24 | — | 156.0% | ||
| Q3 24 | — | 38.1% | ||
| Q2 24 | — | 15.5% | ||
| Q1 24 | -714.4% | 54.8% |
资本支出强度
IMVT
UBFO
| Q4 25 | — | 16.8% | ||
| Q3 25 | — | 6.0% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | — | 0.9% | ||
| Q4 24 | — | 8.7% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 2.2% | ||
| Q1 24 | 1.8% | 3.6% |
现金转化率
IMVT
UBFO
| Q4 25 | — | 6.46× | ||
| Q3 25 | — | 1.73× | ||
| Q2 25 | — | 4.01× | ||
| Q1 25 | — | 1.13× | ||
| Q4 24 | — | 7.87× | ||
| Q3 24 | — | 1.40× | ||
| Q2 24 | — | 0.54× | ||
| Q1 24 | — | 1.79× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图